Imiquimod and Jakafi drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Imiquimod (imiquimod) and Jakafi (ruxolitinib phosphate). Common drug interactions include atrial fibrillation among females and malaise among males.
The phase IV clinical study analyzes what interactions people have when they take Imiquimod and Jakafi. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.
What is Imiquimod?
Imiquimod has active ingredients of imiquimod. eHealthMe is studying from 2,038 Imiquimod users. Check the latest studies of Imiquimod.
What is Jakafi?
Jakafi has active ingredients of ruxolitinib phosphate. It is often used in primary myelofibrosis. eHealthMe is studying from 56,530 Jakafi users. Check the latest studies of Jakafi.
39 people who take Imiquimod and Jakafi together, and have interactions are studied.

What are the common drug interactions of Imiquimod and Jakafi, by gender? *:
female:
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
male:
- Malaise (a feeling of general discomfort or uneasiness)
- Back pain
- Blood iron decreased
- Decreased appetite
- Euphoric mood (excessively happy but may become angry or irritable)
- Gait disturbance
- Herpes zoster
- Intervertebral disc protrusion (spinal disc protrusion)
- Nerve injury
- Weight increased
What are the common drug interactions of Imiquimod and Jakafi, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Malaise (a feeling of general discomfort or uneasiness)
- Back pain
- Decreased appetite
- Euphoric mood (excessively happy but may become angry or irritable)
- Fatigue (feeling of tiredness)
- Gait disturbance
- Herpes zoster
- Intervertebral disc protrusion (spinal disc protrusion)
- Nerve injury
- Weight increased
What are the existing conditions these people have? *
- Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 26 people, 66.67%
- Herpes Zoster: 14 people, 35.90%
- Nerve Injury: 12 people, 30.77%
- Kidney Stones: 8 people, 20.51%
- Precancerous Skin Lesion: 7 people, 17.95%
- Rashes (redness): 3 people, 7.69%
- Polycythaemia (proportion of blood volume that is occupied by red blood cells increases): 3 people, 7.69%
- Joint Pain: 3 people, 7.69%
- Hypersensitivity: 3 people, 7.69%
- High Blood Pressure: 3 people, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Imiquimod and Jakafi?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Imiquimod and Jakafi:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Imiquimod:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Jakafi:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Imiquimod and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Jakafi and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on imiquimod and ruxolitinib phosphate (the active ingredients of Imiquimod and Jakafi, respectively), and Imiquimod and Jakafi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Tacrolimus cause Thrombocytosis? - 4 seconds ago
- Could Fosfomycin Tromethamine cause Overdose? - 11 seconds ago
- Could Cefadroxil cause Taste - Impaired? - 12 seconds ago
- Could Diclofenac cause Electrolyte Imbalance? - 16 seconds ago
- Could Botox cause Marasmus? - 19 seconds ago
- Could Ramipril cause Temperature Intolerance? - 22 seconds ago
- Could Fanapt cause Rashes? - 26 seconds ago
- Muscle Aches and Gastroesophageal Reflux Disease - 26 seconds ago
- Drug interactions of Dupixent and Chantix - 26 seconds ago
- Could Rifinah cause Stools - Watery? - 28 seconds ago